CAPA In-vitro Oocyte Maturation
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Number of mature oocytes
研究概览
简要总结
In vitro oocyte maturation (IVM) is a mild-approach assisted reproductive technology (ART). Because of its simplicity, the more favorable financial implications (reduced cost) for patients, and the lower health risk profile of IVM compared to controlled ovarian stimulation (COS) in polycystic ovary syndrome (PCOS) patients, the use of IVM in selected patients may gain increasing interest. Besides its application in patients with polycystic ovaries, IVM technology may have a role in fertility preservation, where young girls and adult women are facing infertility due to gonadotoxic chemotherapeutic treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Patients aged from 18-50 years old
- •Patients seek fertility preservation services
- •Patients seek oocyte retrieval services
排除标准
- •Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)
结局指标
主要结局
Number of mature oocytes
时间窗: 1 week
Number of mature oocytes after IVM
次要结局
未报告次要终点
研究者
Chung Pui Wah Jacqueline
Associate Professor
Chinese University of Hong Kong